d1 cytoskeletons during differentiation

d1 cytoskeletons during differentiation

142 Developmental Brain Research. 5(I (Its89) t42-i4¢~ Elsevier BRESD 60332 Appearance and localization of pho horylated variants of the high molec...

1MB Sizes 40 Downloads 35 Views

142

Developmental Brain Research. 5(I (Its89) t42-i4¢~

Elsevier BRESD 60332

Appearance and localization of pho horylated variants of the high molecular neurofilament protein in NB2a/dl cytoskeletons during differentiation Thomas B. Shea 1'2, Mary Lou Beermann I and Ralph A. Nixon 1'3 1Ralph Lowell Laboratories, Mailman Research Center, McLean Hospital, Belmont MA 02178 (U.S.A.) and Departments of 2Biological Chemistry and Molecular Pharmacology and 3psychiatry, and 3Program in Neuroscience, Harvard Medical School, Boston, MA 02115 (U.S.A.)

(Accepted 5 July 1989) Key words: Neurofilament; Phosphorylation; Neurite outgrowth; Axonal maturation; Neuronal culture; Neuronal differentiation;

Neuroblastoma; Cytoskeleton

We used immunoblot and immunocytochemical methodologies to characterize the appearance and intracellular localization of the high molecular weight neurofilament subunit (NF-H) within the Triton-insoluble cytoskeleton during the first 5 days of differentiation of mouse NB2a/dl neuroblastoma cells. Hypophosphorylated and partially phosphorylated forms of NF-H were detected in cells before and throughout differentiation. By contrast, some extensively phosphorylated forms of NF-H were first detected on the third day of differentiation and at least one additional 200 kDa isoform was visualized in cytoskeletons only after five days of differentiation. Extensively phosphorylated forms of NF-H were restricted to axonal neurites; by contrast, hypophosphorylated and partially phosphorylated forms of NF-H were present throughout undifferentiated and differentiated cells. The high molecular weight neurofilament subunit (NF-H) undergoes extensive phosphorylation, which profoundly influences its electrophoretic mobility on SDS-gels 2'3'11'17A9'27 and generates microheterogeneous isoforms 6'16'21'23. Since the phosphates are added predominantly to the end-domains of the molecule which protrude from the neurofilament backbone, it has been suggested that phosphorylation may mediate the interaction of neurofilaments with each other and with other cytoskeletal constituents 12'ts'23. This line of reasoning is strengthened by observations that individual phosphate groups are added and removed as neurofilaments enter and advance along a x o n s 14"24'25"27. Various investigators have reported that the appearance of NF-H is delayed relative to that of NF-M and NF-L 2'26'28'3°'31'36. Others, however, have concluded that it is the appearance of extensively phosphorylated forms of NF-H that is delayed rather than the subunit itself 1° and that the earlier findings reflect the fact that anti-NF-H antibodies used in

earlier studies recognize only extensively phosphorylated NF-H subunits 5'6'14'2°'31'35. These latter studies and others 23 have suggested that the appearance of extensively phosphorylated NF-H may be related to the development of axonal cytoskeletal stability. In the present study, we have characterized the sequential appearance and subcellular localization of NF-H and post-translationally modified forms of this subunit generated by phosphorylation within the Triton-insoluble cytoskeleton of mouse NB2a/dl neuroblastoma cells during differentiation and neurite outgrowth. Cells were cultured as described previously 33. To induce the outgrowth of axonal neurites 32,33, the medium was replaced with medium containing 1 mM dibutyryl adenosine 3",5"-cyclic monophosphate (dbcAMP; Sigma) 24 h after plating and the cells were cultured for an additional 1-5 days; these cells are defined as day 1 cells through day 5 cells, respectively, to indicate the length of dbcAMP treatment. Cells not treated with dbcAMP are referred to as day 0 cells.

Correspondence: T.B. Shea, Ralph Lowell Laboratories, McLean Hospital, Belmont, MA 02178, U.S.A.

0165-3806/89/$03.50 (~) 1989 Elsevier Science Publishers B.V. (Biomedical Division)

143 Nitrocellulose replicas of Triton-insoluble cytoskeletons following SDS-gei electrophoresis were prepared as described previously33. The transferred proteins were visualized by sequential reaction of the nitrocellulose with antisera against NF-H (below) followed by secondary antibody conjugated with horseradish peroxidase and diaminobenzidine in the presence of H20 2. Triton-insoluble cytoskeletons of cultures grown in chamber slides (Lab-Tek, Naperville, MD) were fixed and processed for immunocytochemistry as described previously33. Rabbit polyclonal antisera H2 (raised against electrophoretically purified NF-H 4) was a generous gift of Dr. R.E. Majocha (McLean Hospital, Belmont, MA). Monoclonal antibodies directed against non-phosphorylated (SMI-32) and phosphorylated (SMI-31) neurofilament epitopes 35 were obtained from Sternberger-Meyer Immunochemicais (Jarretsville, MD). Monoclonal antibody RT97 ~ was a generous gift of Dr. Ursula C. Drager (Harvard Medical School, Boston, MA). SMI-32, H2 and SMI-31 were diluted 1:1000, and RT97 was diluted 1:500. We characterized by immunoblot analysis NF-H forms present in cytoskeletons of undifferentiated (day 0) NB2a/dl cells, which have only putative neurites, and cytoskeletons from cells after 3 days of differentiation, which have elaborated axonal neurites 32'33. Hypophosphorylated NF-H forms were visualized in day 0 cytoskeletons by SMI-32 (diffuse bands migrating at approximately 160 kDa and 175 kDa; Fig. la) and additional forms migrating at 175-180 kDa were stained by H2 (Fig. lb); however, extensively phosphorylated NF-H forms were not detected in day 0 cytoskeletons (Fig. lc,d). Significant changes were noted in cytoskeleton- associated levels of phosphorylated NF-H during differentiation. In day 3 cytoskeletons, hypophosphorylated NF-H subunits (approximately 160-175 kDa) were observed with SM1-32 at similar levels (Fig. le) as had been detected at day 0. By contrast, in day 3 cytoskeletons, H2 (Fig. lf) and SMI-31 (Fig. lg) labeled a range of more highly phosphorylated NF-H subunits migrating from 175-200 kDa. Additional phosphorylation-dependent NF-H epitopes were first visualized by RT97 at day 5 (Fig. li). Having demonstrated the specificities of these antibodies for NF-H subunits and their phosphorylated variants, we examined the incorporation into

the cytoskeleton and subcellular localization of NF-H forms during neuritogenesis. This is accomplished by performing immunocytochemical analyses of Triton-extracted cytoskeletons from NB2a/dl cells harvested at daily intervals from 0 to 5 days after inducing differentiation with dbcAMP. The antibodies used to examine the appearance and localization of NF-H subunits and variants generated by phosphorylation each yielded unique staining patterns. SMI-32 (Fig. 2, row 1) immunoreactivity was present in putative neuritic cytoskeletons of day 0 cells (Fig. 2a), and underwent a moderate increase in day 1 neuritic cytoskeletons (Fig. 2b); no further increase in neuritic immunoreactivity was observed (Fig. 2c-f). By contrast, perikaryal immunoreactivity increased in day 2 cytoskeletons, and apparently continued to increase during continued dbcAMP treatment (Fig. 2d-f). A similar distribution was observed in immunocytochemical analyses of the middle and low molecular weight neurofilament subunits during differentiation (not shown). Only marginal staining of perikaryai or neuritic cytoskeletons was observed with H2 (Fig. 2, row 2) until day 3 after the addition of dbcAMP, at which time immunoreactivity in perikarya and neurites increased; no further change was detected by day 5 after dbcAMP treatment (Fig, 3a-f). Both SMI-31 and RT97 (below) strongly labeled nuclei. This labeling pattern is thought to reflect the binding of neurofilament subunits by lamins 13 and/or cross-reactivity of these antibodies with histones 37, both of which share antigenic determinants with

a

b

cd

e

fgh

i

Fig. 1. Immunoblot analyses of the appearance of phosphorylated NF-H variants during NB2a/dl differentiation. Tritoninsoluble cytoskeletons from day 0 (a-d), day 3 (e-h) and day 5 (i) cells were immunostained with the following antibodies: SMI-32 (a,e); H2 (b,f); SMI-31 (c,g); RT97 (d,h,i). The migratory positions of 200 kDa, 97 kDa and 68 kDa molecular weight markers are indicated by arrowheads on the left of the figure.

144 neurofllament subunits. The extent of nuclear reactivity with these antibodies apparently decreased during differentiation of NB2a/dl cells (Fig. 4a-f;

Fig. 5a-f), which may reflect alterations in lamin expression during differentiation of these cells. Immunoreactivity with SMI-31 (Fig. 2, row 3) was

C

Fig. 2. Immunocytochemical analyses of the appearance of phosphorylated NF-H variants during NB2a/dl differentiation. Panels a-f represent Triton-extracted cytoskeletons from day 0-5 cells, respectively, which were immunostained with the following antibodies: SMI-32 (row 1); H2 (row 2); SMI-31 (row 3); RT97 (row 4).

145 marginal in p e r i k a r y a and neurites of day 0 - 2 cytoskeletons (Fig. 2 a - c ) . I m m u n o r e a c t i v i t y with SMI-31 first b e c a m e p r o m i n e n t in some neurites by day 3 (Fig. 2d, arrows), and in the m a j o r i t y of neurites by day 4 (Fig. 2e). By comparison, immunostaining with RT97 (except in nuclei) was not d e t e c t e d until 4 days after the addition of d b c A M P (Fig. 2 a - e , row 4) and at this time the staining was restricted to focal regions along the neurite (Fig. 2e, arrows). Staining of the entire neurite with RT97 was first o b s e r v e d in day 5 cytoskeletons, although in s o m e neurites RT97 immunoreactivity was more intense distally than proximally (Fig. 2f, row 4, arrows). Regions of the p e r i k a r y o n near the base of axonal neurites were occasionally labeled with SMI31 in day 4 and 5 cytoskeletons (Fig. 2e,f, rows 3 and 4, arrows); however, staining of the perikaryal cytoskeleton with RT97 was not observed at any time. These results confirm that extensively phosp h o r y l a t e d N F - H subunits are segregated within axonal neurites 33, and also suggest that the majority of h y p o p h o s p h o r y l a t e d N F - H isoforms are localized within the p e r i k a r y o n . These findings in N B 2 a / d l cells suggest, as has been d e m o n s t r a t e d by others (above) that the relative delay in a p p e a r a n c e of extensively phos-

p h o r y l a t e d N F - H isoforms during differentiation is due to d e l a y e d post-translational modification rather than d e l a y e d expression of the N F - H p o l y p e p t i d e . The additional delay in a p p e a r a n c e until day 5 of certain extensively p h o s p h o r y l a t e d epitopes suggests, as has been o b s e r v e d in vivo and in p r i m a r y culture 5-7"9"~j'j42°'3~'35, the presence of multiple

1 Anderton, B.H., Breinburg, D., Downes, M.J., Gree, P.J., Tomilson, B.E., Ulrich, J., Wood, J.N. and Kahn, J., Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants, Nature (Lond.), 298 (1982) 84-86. 2 Bennett, G.S. and DiLullo, C., Expression of a neurofilament protein by the precursors of a subpopulation of ventral spinal cord neurons, Dev. Biol., 107(1985) 94-106. 3 Black, M.M., Keyser, P. and Sobel, E., Interval between the synthesis and assembly of cytoskeletal proteins in cultured neurons, J. Neurosci., 6 (1986) 1004-1012. 4 Brown, B.A., Majocha, R.E., Staton, D.M. and Marotta, C.A., Axonal polypeptides cross-reactive with antibodies to neurofilament proteins, J. Neurochem., 40 (1983) 299-308. 5 Carden, M.J., Schlaepfer, W.W. and Lee, V.M., The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state, J. Biol. Chem., 260 (1985) 9805-9817. 6 Carden, M.J., Trojanowski, J.Q., Schlaepfer, W.W. and Lee. V.M., Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns, J. Neurosci., 7 (1987) 3489-3504. 7 Dahl, D., Labkovsky, B. and Bignami, A., Neurofilament phosphorylation in axons and perikarya: immunofluorescence study of the rat spinal cord and dorsal root ganglia

with monoclonal antibodies, J. Comp. Neurol., 271 (1988) 445-450. Dahl, D., Early and late appearance of neurofilament phosphorylated epitopes in rat nervous system development: in vivo and in vitro study with monoclonal antibodies, J. Neurosci. Res., 20 (1988) 431-44l, Dahl, D. and Bignami, A., Neurofilament phosphorylation in development. A sign of axonal maturation'?, Exp. Cell Res., 162 (1986) 220-230. Dahl, D., Crosby, C., Cardner, E.E. and Bignami, A., Delayed phosphorylation of the largest neurofilament protein in rat optic nerve development, J. Neurosci. Res., 15 (1984) 513-519. Foster, G.A., Dahl, D. and Lee, V.M., Temporal and topographic relationships between the phosphorylated and nonphosphorylated epitopes of the 2(t(/kDa neurofilament protein during development in vitro, J. Neurosci., 7 (1987) 2651-2663. Geisler, N., Kaufmann, E., Fischer, S., Plessmann, U. and Weber, K., Neurofilament architecture combines structural principles of intermediate filaments with carboxyl-terminal extensions increasing in size between triplet proteins, EMBO J., 2 (1983) 1295-1302. Georgatos, S.D. and Blobel, G., Lamin B constitutes an intermediate filament attachment site at the nuclear envelope, J. Cell Biol., 105 (19871 117-125. Glicksman, M.A., Soppet, D. and Willard, M.B., Post-

classes of p h o s p h o r y l a t i o n - d e p e n d e n t N F - H epitopes in N B 2 a / d l cells. These results may therefore reflect the late a p p e a r a n c e and/or activation of distinct neurofilament kinases, as has been suggested for neurons in primary culture 11. Resistance of N B 2 a / d l axonal neurites to retraction following exposure to coichicine is first detected in some neurites at day 3, and has d e v e l o p e d in all neurites by day 73~. The t e m p o r a l correlation between the d e v e l o p m e n t of axonal stability and the a p p e a r a n c e within axons of N F - H subunits which have undergone the post-translational modifications associated with axonal m a t u r a t i o n in vivo suggests that these modified forms may influence neuritic stability in N B 2 a / d l cells. This research was s u p p o r t e d by the Medical Foundation, Inc./Charles A. King Trust, AG05604, and BNS-8719823.

8

9 10

11

12

13 14

146

15

16

17

18

19

20

21

22

23

24

25

translational modification of neurofilament polypeptides in rabbit retina, J. Neurobiol., 18 (1987) 167-196. Glicksman, M.A. and Willard, M., Differential expression of the three neurofilament polypeptides, Ann. N. E Acad. Sci., 455 (1985) 479-491. Goldstein, M.E., Cooper, H.S., Bruce, J.. Carden, M.J.. Lee, V.M. and Schlaepfer, W.W., Phosphorylation of neurofilament proteins and chromatolysis following transection of rat sciatic nerve, J. Neurosci., 7 (1987) 15861594. Goldstein, M.E., Weiss, S.R,, Lazzarini, R.A., Schneidman, RS., Lees, J.E and Schlaepfer, W.W., mRNA levels of all three neurofilament proteins decline following nerve transection, Brain Research, 427 (1988) 287-291. Julien, J.-P. and Mushynski, W.E,, Multiple phosphorylation sites in mammalian neurofilament polypeptides, J. Biol. Chem., 257 (1982) 10467-10470. Julien, J.-P, and Mushynski, W.E., The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments, J. Biol. (;hem., 258 (1983) 4019-4025. Lee, V.M. and Andrews, P.W., Differentiation of NTERA2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins, J, Neurosci., 6 (1986) 514-52l. Lee, V.M., Carden, M.J., Schlaepfer, W.W, and Trojanowski, J.Q., Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats, J. Neurosci., 7 (1987) 3474-3488. Lee, V.M., Otvos Jr., L., Carden, M.J., Hollosi, M., Dietzschold, B. and Lazzarini, R.A., Identification of the major multiphosphorylation site in mammalian neurofilaments, Proc. Natl. Acad. Sci. U.S.A., 85 (1988) 1998-2002. Lewis, S.E. and Nixom R.A., Multiple phosphorylated variants of the high molecular mass subunit of neurofilaments in axons of retinal cell neurons: characterization and evidence for their differential association with stationary and moving neurofilaments, J. Cell Biol., 1(17 (t988) 2689-2701. Nixon, R.A. and Lewis, S.E., Phosphorylation and dephosphorylation of neurofilament proteins in retinal ganglion cell neurons in vivo, Adv. Exp. Med. Biol., 221 (1987) 167-186. Nixon, R,A., Lewis, S.E. and Marotta, C.A., Postransla-

26

27

28

29 30

31

32

33

34

35

36

37

tional modification of neurofilament proteins by phosphate during axoplasmic transport in retinal ganglion cell neurons, J. Neurosci., 7 (1987) 1145-1158. Nona, S.N., Trowell, S.C. and Cronly-Dillon, J.R., Post.natal developmental profiles of filamentous actin and of 21)(I kDa neurofilament polypeptide in the visual cortex of light- and dark-reared rats and their relationship to critical period plasticity, FEBS Left., 186 (1986) 111-115. Oblinger, M.M., Characterization of posttranslational processing of the mammalian high-molecular weight neurofilament protein in vivo, J. Neurosci., 7 (1987) 2510-2521. Patcher, J.S. and Liem, R.K.H., The differential appearance of neurofilament triplet polypeptides in the developing rat optic nerve, Dev. Biol., 103 (1984) 200-21t/. Shaw, G., Neurofilaments: abundant but mysterious neuronal structures, Bioessays, 4 (1986) 161-166. Shaw, G. and Weber, K., Differential expression of the neurofilament triplet proteins within individual neurones, Nature (Lond.), 298 (1982) 277-279. Shaw, G., Osborn, M. and Weber, K., Reactivity of a panel of monoclonal antibodies on phosphorylated and dephosphorylated neurofilaments, Eur. J. Cell Biol.. 42 (1986) I-9. Shea T.B., Fischer, I. and Sapirstein, V.S., Eftects of retinoic acid on growth and morphologic differentiation of mouse NB2a neuroblastoma cells in culture, Dev. Brain Res., 21 (1985) 307-314. Shea, T.B., Sihag, R.K. and Nixon, R.A., Neurofilament triplet proteins of NB2a/dl neuroblastoma: posttranslational modification and incorporation into the cytoskeleton during differentiation, Dev. Brain Res., 43 (1988) 97-109. Shea, T.B. and Nixon, R.A.. Acetylated alpha-tubulin in axonal microtubules of differentiated NB2a/d 1 cells, Trans. Am. Soc. Neurochem., 19 (1988) 176. Sternberger, L.A. and Sternberger, N.H., Monoctonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofi[aments in situ, Proc. Natl. Acad. Sci. U.S.A.. 80 (1983) 6126-6130. Willard, M. and Simon, C., Modulations of neurofilament axonal transport during the development of rabbit retinal ganglion cells, Cell, 35 (1983) 551-559. Wood, J.N,, Lathangue, N.B., McLachlan, D.R., Smith, B.J., Anderton, B.H. and Dowding, A.J., Chromatin proteins share antigenic determinants with neurofilaments, J. Neurochem., (1985) 149-154.